Poland 3D Imaging Market Analysis Report 2022 to 2030

Poland 3D Imaging Market Analysis

$ 3999

Poland's 3D imaging market is projected to grow from $0.18 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by the rising demand for effective diagnostic technologies and advances in imaging technology. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers, and Philips Healthcare.

ID: IN10PLDH001 CATEGORY: Digital Health GEOGRAPHY: Poland AUTHOR: Vidhi Upadhyay

Buy Now

Poland 3D Imaging Market Executive Summary

Poland's 3D imaging market is projected to grow from $0.18 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. According to the World Health Organization Global Health Expenditure database, Poland's health expenditure (as a percentage of GDP) increased from 6.33% in 2018 to 6.45% in 2019. Poland's medical system is facing challenges such as an aging population and growing healthcare costs, but the government is investing in research to improve healthcare quality, accessibility, and efficiency. According to The Global Cancer Observatory 2020, out of a total population of 37.84 Mn, the number of new cases of cancer was 0.2 Mn with 0.11 Mn deaths registered in Poland. In 2021 the number of fatalities in Poland due to cardiovascular disease was reported to be 49,583.000 Persons.

In Poland, 3D Imaging technology offers a wide range of uses, both diagnostic and therapeutic. High-resolution representations of interior organs, bones, and tissues are provided by medical imaging techniques such as X-ray computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound to help in diagnosis. Radiation therapy and virtual surgery planning to employ 3D Imaging to model treatments and procedures, allowing for greater precision and safety. 3D Imaging technology is an important tool for medical professionals in a variety of sectors and plays an important role in healthcare in Poland.

Market Dynamics

Market Growth Drivers

Poland's elderly population is expanding, and there is a growing demand for effective diagnostic technologies to diagnose and treat age-related disorders including cancer and cardiovascular disease. High-quality imaging produced by 3D Imaging technology can assist in the early detection and treatment of such illnesses. In Poland, advances in imaging technology have made 3D Imaging more inexpensive and accessible. This has contributed to the growth of the market for these technologies. Moreover, Poland is increasing its investment in healthcare infrastructure and technology, which is projected to propel the 3D Imaging market forward.

Market Restraints

The cost of 3D Imaging technology might be excessively expensive for some healthcare professionals in Poland, limiting its use in specific circumstances. Some rural parts of Poland have limited access to healthcare services, which may hinder the use of 3D Imaging technology in these areas. In Poland, there is a scarcity of experienced experts educated in the use of 3D Imaging technology. This might slow the adoption of these technologies and create a backlog in the delivery of healthcare services.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Hitachi Healthcare
Sectra AB

Notable Deals

January 2023, Canon Medical Systems Corporation announced a Partnership with ScImage, Inc., as it plans to expand in image exchange solutions and the cardiac market.

November 2022, At RSNA, Philips introduces new AI-enhanced informatics solutions having an integrated diagnostic strategy that combines radiology, cardiology, pathology, and oncology to securely unify data and pictures throughout the organization, allowing for an earlier and more conclusive diagnosis

February 2022, FUJIFILM VisualSonics, a global producer of ultra-high-frequency (UHF) ultrasound imaging systems, collaborated with PIUR IMAGING, the European leader in tomographic ultrasound imaging, to deliver UHF, three-dimensional (3D) ultrasound imaging technology to physicians and researchers. This technical innovation aids clinical research in the evaluation of defects in a variety of applications such as dermatology, neurology, vascular, and MSK.

Healthcare Policies and Regulatory Landscape

The Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products (URPL) is the regulatory entity in Poland in charge of the medical device market. The URPL is in charge of ensuring the safety and efficacy of medical equipment used in Poland, including 3D Imaging devices. In Poland, professional medical groups such as The Polish Medical Society of Radiology (PLTR) play a significant role in promoting the use of 3D Imaging technology and ensuring that medical practitioners are adequately trained in its application.

Reimbursement Scenario

The National Health Fund in Poland covers the cost of 3D Imaging operations (NFZ). The NFZ is Poland's major payer for healthcare services and is in charge of reimbursing medical operations and treatments covered under the National Health Fund's benefit catalog. In Poland, reimbursement rates for 3D Imaging operations vary based on the procedure, the technology utilized, and the location of the healthcare center.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Poland 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.